FindTrial
Sign In

A retrospective study about the target gene sequencing of prostate cancer samples and the correlation research between the KMT2D expression level and disease outcome

A retrospective study about the target gene sequencing of prostate cancer samples and the correlation research between the KMT2D expression level and disease outcome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17012644
Enrollment
Unknown
Registered
2017-09-12
Start date
2015-08-01
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Prostate cancer:nil
Benign prostatic hyperplasia (BPH):nil

Sponsors

Nanfang Hospital, South Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
44 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The patients have been histologically confirmed as PCa by pathologists; 2. Cases received no prostate cancer relevant therapy; 3. Cases with complete clinical information.

Exclusion criteria

Exclusion criteria: Patients cannot complete the follow-up

Design outcomes

Primary

MeasureTime frame
Prostate cancer frequency mutation gene panel;KMT2D immuno -histochemistry staining;H3K4me1 immuno -histochemistry staining;—

Countries

China

Contacts

Public ContactWei Qiang

Nanfang Hospital, South Medical University

weiqiang0915@163.com+86 13380036388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026